The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode Schizophrenia: Is It a Practice Effect?
Abstract
CONTEXT: Cognitive impairment in schizophrenia is frequent, involves multiple domains, and is enduring. Numerous recent clinical trials have suggested that second-generation antipsychotic medications significantly enhance cognition in schizophrenia. However, none of these studies included healthy controls undergoing repeated testing to assess the possibility that improvements might reflect simple practice effects. OBJECTIVE: To report the results on cognition of a randomized comparison of 2 widely prescribed second-generation antipsychotic medications, olanzapine and risperidone, in patients with first-episode schizophrenia and a healthy control group. DESIGN: Randomized clinical trial. SETTING: Hospital-based research units. Patients A total of 104 participants with first-episode schizophrenia and 84 healthy controls. MAIN OUTCOME MEASURES: Cognitive assessment of all study participants occurred at baseline, 6 weeks later, and 16 weeks later. Neurocognitive tests included measures of working memory and attention, speed, motor function, episodic memory, and executive function. RESULTS: No differential drug effects were observed. Of 16 cognitive measures, 9 demonstrated improvement over time and only 2 demonstrated greater rates of change than those observed in the healthy control group undergoing repeated assessment. The composite effect size for cognitive change was 0.33 in the healthy control group (attributed to practice) and 0.36 in the patients with first-episode schizophrenia. Improvements in cognition in the first-episode schizophrenia group could not be accounted for by medication dose, demographic variables, or intellectual level. CONCLUSIONS: The cognitive improvements observed in the trial were consistent in magnitude with practice effects observed in healthy controls, suggesting that some of the improvements in cognition in the first-episode schizophrenia group may have been due to practice effects (ie, exposure, familiarity, and/or procedural learning). Our results also indicated that differential medication effects on cognition were small. We believe that these findings have important implications for drug discovery and the design of registration trials that attempt to demonstrate cognitive enhancement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences
Cohen, P., Cohen, P., West, S. G., & Aiken, L. S. (2014) · Psychology Press eBooks · doi:10.4324/9781410606266 · Cited by 20,737
Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences.
Tufte, E. R., Cohen, J., & Cohen, P. (1979) · Journal of the American Statistical Association · doi:10.2307/2286442 · Cited by 5,180
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Toward an instance theory of automatization.
Logan, G. D. (1988) · Psychological Review · doi:10.1037/0033-295x.95.4.492 · Cited by 3,466
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia
Saykin, A. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020048005 · Cited by 1,086
Keefe, R. S. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.633 · Cited by 1,065
Neuropsychology of First-Episode Schizophrenia: Initial Characterization and Clinical Correlates
Bilder, R. M., Goldman, R. S., Robinson, D., Reiter, G., Bell, L., Bates, J. A., Pappadopulos, E., Willson, D. F., Alvir, J. M. J., Woerner, M. G., et al. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.549 · Cited by 906
Self-citationBowie, C. R., Reichenberg, A., Patterson, T. L., Heaton, R. K., & Harvey, P. D. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.418 · Cited by 763
Human Functional Neuroimaging of Brain Changes Associated with Practice
Kelly, A. M. C., & Garavan, H. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhi005 · Cited by 752
Keefe, R. S. E., Silva, S. G., Perkins, D. O., & Lieberman, J. A. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033374 · Cited by 693
Cornblatt, B. A., Risch, N. J., Faris, G., Friedman, D., & Erlenmeyer-Kimling, L. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90076-5 · Cited by 682
Woodward, N. D., Purdon, S. E., Meltzer, H. Y., & Zald, D. H. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570500516x · Cited by 605
Bilder, R. M., Goldman, R. S., Volavka, J., Czobor, P., Hoptman, M., Sheitman, B., Lindenmayer, J.-P., Citrome, L., McEvoy, J., Kunz, M., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1018 · Cited by 538
Self-citationCognitive Impairments in Patients With Schizophrenia Displaying Preserved and Compromised Intellect
Weickert, T. W., Goldberg, T. E., Gold, J. M., Bigelow, L. B., Egan, M. F., & Weinberger, D. R. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.9.907 · Cited by 538
Self-citationAn instance theory of attention and memory.
Logan, G. D. (2002) · Psychological Review · doi:10.1037/0033-295x.109.2.376 · Cited by 467
Heres, S., Davis, J., Maino, K., Jetzinger, E., Kissling, W., & Leucht, S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.185 · Cited by 450
Buchanan, R. W. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi020 · Cited by 438
Generalized Cognitive Deficits in Schizophrenia: A Study of First-Episode Patients
Mohamed, S., Paulsen, J. S., O'Leary, D., Arndt, S., & Andreasen, N. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.8.749 · Cited by 432
WOODS, S., DELIS, D., SCOTT, J., KRAMER, J., & HOLDNACK, J. (2006) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2006.06.002 · Cited by 401
Neuropsychological Assessment of Monozygotic Twins Discordant for Schizophrenia
Goldberg, T. E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810230082013 · Cited by 384
Self-citationNeuropsychological Deficits in Schizophrenics: Relationship to Age, Chronicity, and Dementia
Heaton, R. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950060033003 · Cited by 381
McGurk, S. R. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi037 · Cited by 374 · cited 1×
“We do not think that our results extend to recent and select cognitive rehabilitation programs that use drills, reinforcement, and meta-cognitive instruction, since they have sometimes resulted in generalizable improvements and vocational successes.(47,48) Occult ceiling and floor effects may have been present in some…”
Longitudinal Neuropsychological Follow-Up Study of Patients With First-Episode Schizophrenia
Hoff, A. L., Sakuma, M., Wieneke, M., Horon, R., Kushner, M., & DeLisi, L. E. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1336 · Cited by 368
Practice effects and the use of alternate forms in serial neuropsychological testing
BEGLINGER, L., GAYDOS, B., TANGPHAODANIELS, O., DUFF, K., KAREKEN, D., CRAWFORD, J., FASTENAU, P., & SIEMERS, E. (2005) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2004.12.003 · Cited by 362 · cited 1×
“Alternate test forms may attenuate but not eliminate practice effects.(45,46) It might also be possible to develop tasks based on the criteria we outlined herein (eg, multiple trials, restricted stimulus set, and high interference) that are relatively resistant to practice effects.”
Keefe, R. S. E., Seidman, L. J., Christensen, B. K., Hamer, R. M., Sharma, T., Sitskoorn, M. M., Lewine, R. R. J., Yurgelun-Todd, D. A., Gur, R. C., Tohen, M., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.985 · Cited by 314
Ridker, P. M., & Torres, J. (2006) · JAMA · doi:10.1001/jama.295.19.2270 · Cited by 303
Longitudinal Study of Cognitive Function in First-Episode and Recent-Onset Schizophrenia
Gold, S., Arndt, S., Nopoulos, P., O’Leary, D. S., & Andreasen, N. C. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1342 · Cited by 296
Keefe, R. S. E., Young, C. A., Rock, S. L., Purdon, S. E., Gold, J. M., & Breier, A. F. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.038 · Cited by 173
Hill, S. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00213-5 · Cited by 168
Harvey, P. D., Rabinowitz, J., Eerdekens, M., & Davidson, M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1888 · Cited by 161
Albus, M., Hubmann, W., Mohr, F., Hecht, S., Hinterberger-Weber, P., Seitz, N.-N., & Küchenhoff, H. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-006-0667-1 · Cited by 143
Long-Term Neurocognitive Effects of Olanzapine or Low-Dose Haloperidol in First-Episode Psychosis
Keefe, R. S. E., Seidman, L. J., Christensen, B. K., Hamer, R. M., Sharma, T., Sitskoorn, M. M., Rock, S. L., Woolson, S., Tohen, M. F., Tollefson, G. D., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.022 · Cited by 131
Another view of therapy for cognition in schizophrenia
Carpenter, W. T., & Gold, J. M. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01399-9 · Cited by 127
Albus, M., Hubmann, W., Mohr, F., Tiedemann, T. V., Pechler, S., Drießlein, D., & Küchenhoff, H. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-01030-z · Cited by 121
Hinton-Bayre, A. D., & Geffen, G. M. (2005) · Psychological Assessment · doi:10.1037/1040-3590.17.2.237 · Cited by 114
Weickert, T. W., Terrazas, A., Bigelow, L. B., Malley, J. D., Hyde, T. M., Egan, M. F., Weinberger, D. R., & Goldberg, T. E. (2002) · Learning & Memory · doi:10.1101/lm.49102 · Cited by 112
Self-citationRobinson, D. G., Woerner, M. G., Napolitano, B. A., Patel, R. C., Sevy, S. M., Gunduz‐Bruce, H., Soto-Perello, J. M., Mendelowitz, A. J., Khadivi, A., Miller, R., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.12.2096 · Cited by 109
Self-citationLencz, T., Bilder, R. M., Turkel, E., Goldman, R. S., Robinson, D., Kane, J. M., & Lieberman, J. A. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.3.238 · Cited by 89
Self-citationUchiyama, C. L., D'Elia, L. F., Dellinger, A. M., Becker, J. T., Selnes, O. A., Wesch, J. E., Chen, B. B., Satz, P., van Gorp, W., & Miller, E. N. (1995) · Archives of Clinical Neuropsychology · doi:10.1016/0887-6177(94)e0034-m · Cited by 80
Weickert, T. W., Goldberg, T. E., Marenco, S., Bigelow, L. B., Egan, M. F., & Weinberger, D. R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300216 · Cited by 76
Self-citationTheisen, M. E., Rapport, L. J., Axelrod, B. N., & Brines, D. B. (1998) · Assessment · doi:10.1177/107319119800500110 · Cited by 72
Learning and forgetting in schizophrenia.
Gold, J. M., Rehkemper, G., W., I. B. S., Carpenter, C. J., Fleming, K., Goldberg, T. E., & Weinberger, D. R. (2000) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.109.3.534 · Cited by 69
Self-citationPractice-related improvement in information processing with novel antipsychotic treatment
Harvey, P. D., Moriarty, P. J., Serper, M. R., Schnur, E., & Lieber, D. G. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00033-5 · Cited by 64
Stability of Cognitive Performance in Older Patients With Schizophrenia: An 8-Week Test-Retest Study
Harvey, P. D., Palmer, B. W., Heaton, R. K., Mohamed, S., Kennedy, J., & Brickman, A. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.110 · Cited by 62
Cited by
van Os, J., & Kapur, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60995-8 · Cited by 1,971
Neurocognition in first-episode schizophrenia: a meta-analytic review.
Mesholam-Gately, R. I., Giuliano, A. J., Goff, K. P., Faraone, S. V., & Seidman, L. J. (2009) · Neuropsychology · doi:10.1037/a0014708 · Cited by 1,130
Schizophrenia Is a Cognitive Illness: Time for a Change in Focus
Kahn, R. S., & Keefe, R. S. E. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.155 · Cited by 825
A systematic review and meta-analysis of exercise interventions in schizophrenia patients
Firth, J., Cotter, J., Elliott, R., French, P., & Yung, A. R. (2015) · Psychological Medicine · doi:10.1017/s0033291714003110 · Cited by 600
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Metadata
- Authors
- Goldberg, T. E., Goldman, R. S., Burdick, K. E., Malhotra, A. K., Lencz, T., Patel, R. C., Woerner, M. G., Schooler, N. R., Kane, J. M., & Robinson, D. G.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2007-10-01
- Volume
- 64
- Issue
- 10
- Pages
- 1115
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2073442736
- Cited by
- 394
- References
- 45
- FWCI
- 21.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.